Wedbush reiterates Outperform on Nuvation Bio; $11 price target
Wedbush reiterated an Outperform rating on Nuvation Bio and set a $11.00 price target, implying 89.7% upside versus the Sep 15 close of $5.80.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.